Moving Beyond Linear Dimensions: Using Stone Volume to Better Predict High-Complexity PCNL Outcomes
Grant Sajdak, Katya Hanessian, Ala’a Farkouh, Sophia Kalanski, Ruben Crew, Daniel Jhang, Ali Albaghli, Zhamshid Okhunov, D. Duane BaldwinIntroduction and Objective:
Stone diameter, measured in a single dimension, is used for management, billing, and research. Recent evidence has supported the use of stone volume over diameter. The purpose of this study was to compare stone volume and diameter as a predictor for outcomes following percutaneous nephrolithotomy (PCNL).
Methods:
A retrospective review was performed on PCNL patients at a single academic institution between January 2017 and June 2022. Preoperative computed tomography scans were analyzed to assess maximal stone diameter and stone volume using both Enterprise Imaging (ENI) and the scalene ellipsoid formula (ELF). Diameters and volumes were compared and analyzed for association with clinical and operative variables. Statistical analysis was performed using Spearman’s rho and binary logistic regression (
Results:
Among 220 patients, the mean stone diameter was 24.2 mm. The mean stone volume varied by method: 4580 ± 500 mm
3
using ENI and 6280 ± 1390 mm
3
using the scalene ELF. On univariate analysis, Enterprise and the scalene ELF both significantly correlated with length of stay (ρ = 0.269 and 0.198, respectively,
Conclusion:
Accurate stone volume assessment correlates more strongly with many pertinent PCNL outcomes than scalene ELF and diameter. Utilization of accurate stone volume in clinical practice could better predict patient outcomes, improve guidelines, and standardize research in high-complexity PCNL.